Insider buying last 90 days
No open-market insider purchases were filed for RELX in the last 90 days.
From Form 4 filings, dated to when each was filed.
RELX's recent move centers on its Scientific, Technical & Medical division, where the company highlighted an acceleration in STM growth to 6%, driven by higher-value research and healthcare decision-support products and artificial intelligence-enabled tools. This followed an investor seminar on 3 November and a prior trading update that reaffirmed full-year guidance. Separately, Bernstein maintained a Buy rating on RELX and raised its target price to $50.35, while coverage this week also framed the stock in a comparison against YELP on relative value.
RELX closed at $41.08, up 4.3%, sitting above both its 50-day average of $36.15 and its 200-day average of $34.48, consistent with an ongoing uptrend despite one-year returns of -7%. The GekkoIndex reads 46.1, placing the stock in the Neutral zone, down 2.1 over five days. Gekko Fair Value stands at $52.44, putting the current price 21.7% below that level.
Looking ahead, RELX's next earnings report is scheduled for 18 February 2027, 105 days out and beyond a typical 20-trading-day holding window. No insider, Congress, or unusual options activity appears in the respective 90-day and 30-day windows. Seasonality data covering five years shows the next 20 trading days from this point averaging a 1.3% return, with gains in 3 of those years. Analyst consensus, from two firms, carries a target of $53.35, implying upside of 29.9%.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
RELX scores 4 supportive, 1 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive1 mixed0 headwinds
Above 50 and 200-day
Close $41.08 is above the 50-day ($36.15) and 200-day ($34.48) averages, and the 50-day is above the 200-day.
See the chart46.1, Neutral
Reading 46.1 is in the Neutral zone.
See the GekkoIndex21.7% below
Price is 21.7% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 105 days
Next report Feb 18, 2027, 105 days away — outside a typical 20-trading-day hold.
See earnings+1.3% on average
From this point in the calendar, the next 20 trading days averaged +1.3% over 5 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
RELX closed at $41.08 on Nov 4, 2026, −7.0% over the past year, inside a 52-week range of $27.57 to $44.79.
Use the left and right arrow keys to read daily values.
Put RELX on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
RELX supplies data-driven analytics and decision-making tools to professional and corporate customers across North America, Europe and other regions. It is best known for combining large data sets with technology and algorithms to help organizations assess risk, access scientific and medical knowledge, and navigate legal and regulatory matters.
The company works through four divisions. Risk builds analytical platforms and decision support systems that draw on public and specialized data to help clients evaluate and anticipate risk. Scientific, Technical & Medical delivers information and analysis aimed at supporting research and improving healthcare outcomes for institutions and professionals. Legal offers legal, regulatory and business intelligence along with analytical tools to support client decisions and efficiency. Exhibitions runs a group of events that pair in-person gatherings with digital and data tools, helping participants track market developments, discover products and conduct business.
RELX traces its origins to 1903, when it was known as Reed Elsevier PLC, and took its present name in July 2015. Its headquarters are in London, United Kingdom, and its shares are listed under the ticker RELX.
RELX’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 46.1, in the Neutral zone, down 2.1 points over five sessions.
Down 2.1 points over five sessions.
Reading for Nov 4, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 54 | −1.6% | +2.1% | ||
| Accumulation | 225 | +0.6% | +1.8% | ||
| Neutral (current zone) | 352 | −0.1% | −1.4% | ||
| Distribution | 19 | 0.0% | −3.2% | ||
| Selling | 0 | Not available | |||
Average RELX share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.0% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
RELX trades 21.7% below Gekko Fair Value of $52.44, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what RELX shares are worth, recalculated every trading day.
$52.44
Gekko Fair Value, Nov 4, 2026
21.7% Undervalued
At the end of Aug 2026 the price was 26.9% below the estimate.
No open-market insider purchases were filed for RELX, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for RELX in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in RELX were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
RELX reports on Feb 18, 2027, before the open (105 days away), and beat the EPS estimate in 2 of its last 8 reports.
Feb 18, 2027
Expected before the open, 105 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 23, 2026 | $0.91 est $0.89 | $6.49B est $6.54B | +5.1% |
| Apr 23, 2026 | $0.00 est $0.00 | — | +0.7% |
| Feb 12, 2026 | $0.79 est $0.85 | $6.62B est $6.70B | +12.0% |
| Oct 24, 2025 | $0.00 est $0.00 | — | +1.5% |
| Jul 24, 2025 | $0.72 est $0.56 | $6.46B est $6.45B | −0.7% |
| Apr 25, 2025 | $0.00 est $0.00 | — | +0.4% |
| Feb 13, 2025 | $0.78 est $0.80 | $6.19B est $6.45B | −0.7% |
| Oct 24, 2024 | $0.66 est $0.77 | $5.87B est $6.12B | +1.3% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for RELX is $53.35, +29.9% from the last close, from 2 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 2 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 4 | Bank of America Securities | — | — |
| Oct 22 | Citi | — | — |
| Oct 22 | Bank of America Securities | — | — |
| Sep 29 | Bank of America Securities | — | — |
| Sep 18 | Bank of America Securities | — | — |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 4, RELX averaged +1.3% across the last 5 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.2% | 3 of 5 |
| Next 10 trading days | −1.0% | 2 of 5 |
| Next 15 trading days | +0.5% | 2 of 5 |
| Next 20 trading days | +1.3% | 3 of 5 |
| Next 30 trading days | +0.8% | 2 of 5 |
For scale, RELX’s typical 20-trading-day move in either direction is about 4.2%.
RELX’s market cap is $71.30B, with a P/E ratio of 24.2 and revenue of $9.72B over the last twelve months.
Coverage of RELX this week reads neutral: 2 positive, 5 neutral and 1 negative headlines.
RELX’s market cap is $71.30B at the Nov 4, 2026 close of $41.08, with 1.74B shares outstanding. The shares trade on a P/E ratio of 24.2.
The consensus analyst 12-month price target for RELX is $53.35, +29.9% from the last close. Of the 2 firms that rated the stock in the last 90 days, 1 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate RELX is undervalued: the Nov 4, 2026 close of $41.08 is 21.7% below Gekko Fair Value of $52.44. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
RELX is expected to report on Feb 18, 2027, before the market opens (105 days away). Analysts expect earnings of $0.91 per share on revenue of $6.83B. RELX beat the earnings estimate in 2 of its last 8 reports, moving 2.8% on average across the report.
RELX’s 52-week high is $44.79 and its 52-week low is $27.57; it closed at $41.08 on Nov 4, 2026, −7.0% over the past year. Over the last five years the shares peaked at $56.33 on May 27, 2025.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 5 items with data read as supportive (trend, fair value, earnings risk and seasonality), 1 as mixed (gekkoindex). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.